Desperate Indian Communities Embrace Anti-Malaria Drugs To Protect Against COVID Surge

Share:

For the past month and a half, the international community has watched in horror as India has suffered from one of the world’s deadliest national outbreaks of COVID-19, provoked in part by a prime minister who held massive political rallies, and allowed massive gatherings for the celebration of Hindu religious holidays, gatherings that epidemiologists say helped seed the latest outbreak.

Even as the US and Europe have sent vaccines, medicine, oxygen tanks and other supplies, the government has refused to impose more restrictive measures, and the number of daily deaths has continued to accelerate.

The number of deaths eclipsed 4K on Thursday, topping that level for the second day in a row, as hundreds of patients succumbed to the disease while waiting in ambulances and cars in lengthy queues stretching from the nation’s overrun hospitals.

As doctors search for alternatives to remedies like Gilead’s remdesevir, a recent Reuters report highlighted just how desperate communities have become to protect against the virus. The situation is so dire, a small number of communities have embraced the unconventional strategy of dosing their populations with anti-malarial drugs to protect against COVID-19 – even though anti-malarial treatments like hydroxychloroquine supposedly don’t function as a COVID-19 prophylactic (that is, according to certain studies widely cited by the medical establishment. Others suggest that the strategies being used by these communities just might work).

Reuters reports that at least two Indian states have said they plan to dose their populations with the anti-parasitic drug ivermectin to protect against severe COVID-19 infections. And they’re moving ahead with this plan despite the WHO’s statement in late March that the current evidence is “inconclusive”. – READ MORE

Listen to the insightful Thomas Paine Podcast Below --

Share:
No Comments Yet

Leave a Reply

2021 © True Pundit. All rights reserved.